View Older Stories View More Recent Stories
-
Kodiak Gas Services Inc (KGS) PT Raised to $64 at RBC Capital
-
Paychex (PAYX) PT Lowered to $102 at RBC Capital
-
RBC on Micron (MU): 'Structural positives and cyclical tailwinds drive another strong quarter'
-
4D Molecular Therapeutics (FDMT) PT Raised to $35 at RBC Capital
-
Orchid Island Capital Announces March 2026 Monthly Dividend and February 28, 2026 RMBS Portfolio Characteristics
-
Bicycle Therapeutics (BCYC) PT Lowered to $7 at RBC Capital
-
RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
-
HealthEquity, Inc (HQY) PT Lowered at RBC Capital; 'Momentum carries on in a tough environment'
-
Docusign Inc. (DOCU) PT Lowered to $55 at RBC Capital
-
RBC Capital on Constellation Brands (STZ): 'We would view any margin reset related pull back as an attractive opportunity'
-
Nestlé Holdings, Inc. Announces Expiration and Results of Cash Tender Offers for Any and All of its Certain Outstanding Notes
-
RBC Capital Upgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Outperform
-
BHP's new CEO seeks to firm ties in a rapidly changing world
-
RBC Capital Starts Weatherford International plc (WFRD) at Outperform
-
Bunge prices $1.2 billion senior notes offering
-
Bunge Global SA Announces Pricing of $1.2 Billion Senior Notes Offering
-
Australia's Woodside Energy makes Liz Westcott its permanent CEO
-
RBC Capital Downgrades Starbucks (SBUX) to Sector Perform
-
RBC Negative on The Trade Desk (TTD) News
-
Nestlé Holdings, Inc. Announces the Pricing Terms of Cash Tender Offers for Any and All of its Certain Outstanding Notes
-
Fidium Closes on $665 Million Asset Backed Securitization
-
RBC Capital on Bausch & Lomb Corp. (BLCO): 'We view the delay in anticipated competition in the US Rx DED market as neutral to slightly positive'
-
RBC: 'We estimate ZG's initial set of partners represents listings volume roughly 60-80% higher than Compass'
-
RBC Capital: 'War in Iran and the aerospace aftermarket'
-
Rhythm Pharmaceuticals (RYTM) PT Lowered to $130 at RBC Capital
-
Perspective Therapeutics Inc (CATX) PT Lowered to $14 at RBC Capital
-
RBC Capital Reiterates Outperform Rating on Block Inc. (XYZ)
-
RBC Capital 'Expecting a Muted Quarter' for General Mills (GIS)
-
RBC Capital Starts Ryan Specialty Group (RYAN) at Outperform, 'Specialty Leadership at a Discounted Valuation'
-
RBC Capital Starts Goosehead Insurance Inc. (GSHD) at Sector Perform
-
RBC Capital Starts Arthur J. Gallagher (AJG) at Outperform, 'Multi-Decade Winner at Discounted Valuation'
-
RBC Capital Reiterates Outperform Rating on CrowdStrike Holdings (CRWD)
-
RBC Capital on American Express (AXP): 'Consistent year over year growth trends and stable credit'
-
RBC Capital: 'Net, we'd view a constructive agreement...as a net positive for FBIN'
-
RBC: 'Our focus for LLY remains on the pending Orfo approval and subsequent launch'
-
RBC Capital on Implications of Iran Conflict and Surging Oil Prices on Multi-Industry Companies
-
MDA Space completes $300 million US IPO at $30.50 per share
-
Ardent Health Partners Inc (ARDT) PT Lowered to $13 at RBC Capital
-
Universal Health Services (UHS) PT Lowered to $216 at RBC Capital
-
MDA SPACE ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING IN THE UNITED STATES
-
4DMT to Participate in Upcoming Investor Meetings
-
Bombardier Commences Consent Solicitations with Respect to its 7.35% Debentures due 2026 and its 7.450% Notes due 2034
-
DPM Metals Announces Renewal of Normal Course Issuer Bid
-
Altus Group Announces Commencement of Substantial Issuer Bid
-
Micron gains as leading brokers raise targets on continued pricing strength
-
Janus Living launches IPO of 37 million shares at $18-20 price range
-
Healthpeak Properties and Janus Living Announce Launch of Janus Living Initial Public Offering
-
Micron Technology (MU) PT Raised to $525 at RBC Capital
-
Archrock (AROC) PT Raised to $40 at RBC Capital
-
Iran holds the key to reopening global energy markets
